Use of mineralocorticoid receptor antagonist in ST elevation myocardial infarction

被引：1
|
作者：
Khan, Muhammad H. [1 ]
Gerson, Myron C. [2 ,3 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Dept Cardiovasc Med, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, 231 Albert Sabin Way, Cincinnati, OH 45267 USA
来源：
JOURNAL OF NUCLEAR CARDIOLOGY | 2022年 / 29卷 / 05期
关键词：
SYMPATHETIC-NERVE ACTIVITY; HEART-FAILURE; SPIRONOLACTONE; DYSFUNCTION; DENERVATION; EPLERENONE;
D O I：
10.1007/s12350-021-02801-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2336 / 2339
页数：4
相关论文
共 50 条
  • [21] Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
    Shah, Monarch
    Awad, Alaa S.
    Abdel-Rahman, Emaad M.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [22] A selective antagonist of mineralocorticoid receptor eplerenone in cardiology practice
    Gegenava, B. B.
    Drapkina, O. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 177 - 181
  • [23] Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects
    Garg, R.
    Kneen, L.
    Williams, G. H.
    Adler, G. K.
    DIABETES OBESITY & METABOLISM, 2014, 16 (03) : 268 - 272
  • [24] Aldosterone Receptor Antagonist Use After Myocardial Infarction. Data From the REICIAM Registry
    Lopez-de-Sa, Esteban
    Martinez, Angel
    Anguita, Manuel
    Dobarro, David
    Jimenez-Navarro, Manuel
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (11): : 981 - 987
  • [25] Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction
    Fraccarollo, Daniela
    Berger, Stefan
    Galuppo, Paolo
    Kneitz, Susanne
    Hein, Lutz
    Schuetz, Guenther
    Frantz, Stefan
    Ertl, Georg
    Bauersachs, Johann
    CIRCULATION, 2011, 123 (04) : 400 - U354
  • [26] Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction
    Gueret, Alexandre
    Harouki, Najah
    Favre, Julie
    Galmiche, Guillaume
    Nicol, Lionel
    Henry, Jean-Paul
    Besnier, Marie
    Thuillez, Christian
    Richard, Vincent
    Kolkhof, Peter
    Mulder, Paul
    Jaisser, Frederic
    Ouvrard-Pascaud, Antoine
    HYPERTENSION, 2016, 67 (04) : 717 - 723
  • [27] Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances
    Galuppo, Paolo
    Bauersachs, Johann
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (10) : 1112 - 1120
  • [28] Changing patterns of ST elevation myocardial infarction epidemiology
    Bolognese, Leonardo
    AMERICAN HEART JOURNAL, 2010, 160 (06) : S1
  • [29] Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure
    Iqbal, Javaid
    Parviz, Yasir
    Pitt, Bertram
    Newell-Price, John
    Al-Mohammad, Abdallah
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (02) : 143 - 150
  • [30] Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction
    Bedrouni, Wassim
    Sharma, Abhinav
    Pitt, Bertram
    Lam, Carolyn S. P.
    Ni, Jiayi
    Ferreira, Joao Pedro
    McMurray, John
    Giannetti, Nadia
    Girerd, Nicolas
    Rossignol, Patrick
    Solomon, Scott D.
    Claggett, Brian
    Pocock, Stuart
    Huynh, Thao
    Zannad, Faiez
    CIRCULATION-HEART FAILURE, 2022, 15 (10)
12345